There’s always a better way.


Sarisa is toppling accepted therapeutic limitations that affect many. Our early-stage disruptions are elegant, effective and surprisingly common sense.


ONOCOLOGY – OUTPATIENT – OTC

CANCER



Why take just one path?

Introducing a new class of chemical entities in the war against cancer. Typically, a single molecule is entered into the target to attack cancer cells. Our two-molecule system targets dual pathways, significantly increasing the speed and likelihood of shutting down cancerous cells.

STATUS
Currently in animal trials

TECH PARTNER
University of Michigan
2 molecules, 2 pathways for
better patient outcomes

HERBAL ASPRIN



Is food the pathway to the stomach?

Aspirin is a well-known therapeutic and stomach disruptor. Merging Eastern medicine, we’ve found ginger- and resveratrol-based buffers that minimize or eliminate stomach upset while delivering more rapid metabolization and direct effects.

STATUS
5th round patient trials,
ready for commercialization


TECH PARTNER
Dr. Xiu Lu
plant-based buffers mitigate aspirin upset

Interested in a partnership?


We are always open to conversations about emergent technologies and partnerships in the cause of better care.